CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

NIC

  • Articles
  • Pacients
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
30 August 2024

Exciting news in Sonogenetics: A New Frontier for Deep Tissue Treatment

Researchers have made a discovery that could change how we treat some diseases deep within the human body. This technique, known as sonogenetics, combines the power of ultrasound with genetically engineered cells to deliver ...

Graphical Abstract Sonogenetics
  • Events
  • Researchers
  • CTGCT
  • NIC
  • Gregor Cuzak
12 August 2024

ADVANCE Workshop in June 2024

A diverse organising committee of various faculties from the University of Ljubljana organised a 5-day workshop called ADVANCE dedicated to translational medicine for advanced therapy medicinal products (ATMPs). Our Darja Marolt Presen participated. The ...

Advance 2024
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
17 July 2024

CTGCT about on/off switching of CAR-Ts at the EBMT 2024

Assoc. Prof Dr Mojca Benčina, head of the newly founded Slovenian Centre for the Technologies of Gene and Cell Therapy (CTGCT), gave a speech at the recent 50th Annual Meeting of the European Society ...

Featured Up Regulation
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Business Model
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Logistics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • UCL
  • Gregor Cuzak
17 July 2024

UCL ATMP Pipeline

Our partner University College London (UCL) have produced a great short brochure (link) showing the strength and depth  of their pipeline of ATMPs. They use a managed portfolio approach in which they support ~100 ...

Pipeline By Number Of Projects
  • Clinicians
  • Pacients
  • Researchers
  • Business Model
  • Charite Berlin
  • CTGCT
  • NIC
  • UCL
  • UMCUtrecht
  • Gregor Cuzak
8 July 2024

The Promise and Price of Advanced Therapies

Here’s what Claude Sonnet 3.5 has to answer when we question it: why do ATMPs cost so much? Advanced Therapy Medicinal Products (ATMPs), including gene and cell therapies, represent a revolutionary frontier in medicine, ...

Firefly High Cost Medicinal Treatment, In Blue To White; Syringe And Money 24649
  • Events
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Clinic study
  • Marketaccess
  • Regulation
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • UMCUtrecht
  • Gregor Cuzak
1 July 2024

Panel Discussion on ATMP Regulation

The CTGCT organised its first Panel Discussion on 29 May entitled: ATMP Regulation. The main takeaway from the very successful session was that the strong potential of the Slovenian ecosystem requires the will to ...

  • Interview
  • Researchers
  • Datamanagement
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
27 June 2024

Interview with Shivang Khandewal – collaborator of NIC and CTNNB1

Originally from India, Shivang Khandelwal is presently engaged in advanced studies at the Hebrew University of Jerusalem. His primary research focus is on PCDH19 cluster epilepsy, a neurodevelopmental and neuropsychiatric disorder. He is deeply ...

Shivang Khandelwal
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • GMP
  • Clinic study
  • Datamanagement
  • Drug Discovery
  • Ethicalcommittee
  • Investment
  • Laboratory
  • Logistics
  • Manufacturing Process
  • Modalitetadelovanjazdravila
  • Pharmacodynamics
  • Pharmacokinetics
  • Pre Clinical
  • Raw Material
  • Regulation
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
26 June 2024 Event Date: 14 June 2024 • 09:00 − 17:00

CTNNB1 Conference – One Year to Cure

One year to cure is the goal shared by parents of children with the CTNNB1 Syndrome rare disease. Out of approximately 400 known cases worldwide, 82 families with children gathered at the conference in ...

  • Articles
  • Researchers
  • Drug Discovery
  • Research
  • NIC
  • Mojca Bencina
20 June 2024

Protein Gas Vesicles – Potential to Improve Therapy, published in ACS Nano

Ultrasound is a useful method in diagnostics, as it enables a deep and non-invasive observation of the body. Under certain conditions, ultrasound can stimulate cells, but this effect is very small and to amplify ...

Posts pagination

1 2 3

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna